Cook Jennifer E. — SEC insider filings

SEC reporting owner CIK 1754371. 29 insider filings on record with FilingPulse; latest filed 2026-09-02.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2020-11-18 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BridgeBio Pharma, Inc. (BBIO)Director10—6 legs · 278,192 sh · $21,920,43526
Jazz Pharmaceuticals plc (JAZZ)Director11—5 legs · 3,584 sh · $502,61712
Denali Therapeutics Inc. (DNLI)Director8—1 leg · 1,458 sh · $31,68214

Insider filings — Cook Jennifer E.

FiledFormIssuerReported transactionsSource
2026-09-024Jazz Pharmaceuticals plc (JAZZ)Tax withholding (F): 14 @ $244.06 · Tax withholding (F): 1,692 @ $241.39EDGAR
2026-08-074Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 1,605 @ $0EDGAR
2026-07-134BridgeBio Pharma, Inc. (BBIO)Option exercise (M): 19,000 @ $8.45 · Option exercise (M): 112,422 @ $29 · Option exercise (M): 17,167 @ $16.75 · Sale (S): 36,167 @ $84 · Sale (S): 112,422 @ $90 · Option exercise (M): 19,000 (derivative) @ $0 · +2 moreEDGAR
2026-06-244BridgeBio Pharma, Inc. (BBIO)Grant/award (A): 3,990 @ $0 · Sale (S): 2,196 @ $68.57 · Option exercise (M): 20,000 @ $8.45 · Option exercise (M): 17,167 @ $16.75 · Sale (S): 37,167 @ $70 · Grant/award (A): 5,277 (derivative) @ $0 · +2 moreEDGAR
2026-06-174BridgeBio Pharma, Inc. (BBIO)Option exercise (M): 65,921 @ $8.45 · Option exercise (M): 17,167 @ $16.75 · Sale (S): 88,737 @ $66.62 · Sale (S): 1,503 @ $67.14 · Option exercise (M): 65,921 (derivative) @ $0 · Option exercise (M): 17,167 (derivative) @ $0EDGAR
2026-06-054Denali Therapeutics Inc. (DNLI)Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0EDGAR
2025-08-114Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 3,507 @ $0 · Tax withholding (F): 1,805 @ $111.25EDGAR
2025-06-244BridgeBio Pharma, Inc. (BBIO)Grant/award (A): 6,589 @ $0 · Grant/award (A): 8,425 (derivative) @ $0EDGAR
2025-06-054Denali Therapeutics Inc. (DNLI)Grant/award (A): 6,037 @ $0 · Grant/award (A): 18,111 (derivative) @ $0EDGAR
2024-08-064Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 3,731 @ $0 · Tax withholding (F): 1,484 @ $111.35EDGAR
2024-06-254BridgeBio Pharma, Inc. (BBIO)Grant/award (A): 26,014 (derivative) @ $0EDGAR
2024-06-104Denali Therapeutics Inc. (DNLI)Sale (S): 1,458 @ $21.73EDGAR
2024-06-044Denali Therapeutics Inc. (DNLI)Grant/award (A): 5,967 @ $0 · Grant/award (A): 17,901 (derivative) @ $0EDGAR
2023-12-064Jazz Pharmaceuticals plc (JAZZ)Sale (S): 417 @ $119.27EDGAR
2023-08-154Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 3,075 @ $0 · Sale (S): 1,241 @ $138.16EDGAR
2023-06-234BridgeBio Pharma, Inc. (BBIO)Grant/award (A): 51,501 (derivative) @ $0EDGAR
2023-06-054Denali Therapeutics Inc. (DNLI)Grant/award (A): 4,216 @ $0 · Grant/award (A): 12,649 (derivative) @ $0EDGAR
2023-02-214BridgeBio Pharma, Inc. (BBIO)Option exercise (M): 3,576 · Option exercise (M): 3,576 (derivative) @ $0EDGAR
2022-12-064Jazz Pharmaceuticals plc (JAZZ)Sale (S): 420 @ $154.68EDGAR
2022-08-094Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 2,561 @ $0 · Sale (S): 1,089 @ $152.32EDGAR
2022-06-244BridgeBio Pharma, Inc. (BBIO)Grant/award (A): 104,921 (derivative) @ $0EDGAR
2022-06-064Denali Therapeutics Inc. (DNLI)Grant/award (A): 5,986 @ $0 · Grant/award (A): 17,959 (derivative) @ $0EDGAR
2021-12-064Jazz Pharmaceuticals plc (JAZZ)Sale (S): 417 @ $121.30EDGAR
2021-08-024Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 2,246 @ $0EDGAR
2021-06-224BridgeBio Pharma, Inc. (BBIO)Grant/award (A): 38,895 (derivative) @ $0EDGAR
2021-06-044Denali Therapeutics Inc. (DNLI)Grant/award (A): 2,074 @ $0 · Grant/award (A): 6,222 (derivative) @ $0EDGAR
2021-06-034Denali Therapeutics Inc. (DNLI)Option exercise (M): 3,253 @ $0 · Option exercise (M): 3,253 (derivative) @ $0EDGAR
2021-03-014Jazz Pharmaceuticals plc (JAZZ)Grant/award (A): 2,590 @ $0 · Grant/award (A): 6,475 (derivative) @ $0EDGAR
2020-11-184BridgeBio Pharma, Inc. (BBIO)Option exercise (M): 3,576 · Option exercise (M): 3,576 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1754371 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs